The objective response rate in the sequential cohort was lower at 20%. receptor (an extracellular domain name derived from tumor-specific antibody, linked to an intracellular signaling domain name). One study screened human lymphocytes and also immunized transgenic mice to generate TCRs with high avidity for melanoma-associated antigens (MART-1 and gp100). Continue Reading